|
DIS3L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69050999999643E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.671760E-02 |
| Normal-vs-Stage2 |
6.271800E-02 |
| Normal-vs-Stage3 |
1.05140000039583E-08 |
| Normal-vs-Stage4 |
8.01590000043539E-07 |
| Stage1-vs-Stage2 |
5.833200E-01 |
| Stage1-vs-Stage3 |
2.01209999999286E-05 |
| Stage1-vs-Stage4 |
3.979900E-04 |
| Stage2-vs-Stage3 |
3.780400E-02 |
| Stage2-vs-Stage4 |
5.329600E-02 |
| Stage3-vs-Stage4 |
9.171200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.87276999999986E-05 |
| Normal-vs-AfricanAmerican |
2.217100E-03 |
| Normal-vs-Asian |
8.804300E-02 |
| Caucasian-vs-AfricanAmerican |
6.986400E-01 |
| Caucasian-vs-Asian |
9.104400E-01 |
| AfricanAmerican-vs-Asian |
9.682800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.79554999999443E-05 |
| Normal-vs-Female |
3.813800E-04 |
| Male-vs-Female |
5.331000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.376300E-04 |
| Normal-vs-Age(41-60Yrs) |
9.789600E-04 |
| Normal-vs-Age(61-80Yrs) |
2.1121999999929E-05 |
| Normal-vs-Age(81-100Yrs) |
1.016690E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.079400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.914000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.907600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.955000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.436200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.305600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.984400E-01 |
| Normal-vs-Grade 2 |
1.964370E-02 |
| Normal-vs-Grade 3 |
1.64331999999989E-05 |
| Normal-vs-Grade 4 |
7.88059617562453E-11 |
| Grade 1-vs-Grade 2 |
4.077800E-01 |
| Grade 1-vs-Grade 3 |
8.743800E-02 |
| Grade 1-vs-Grade 4 |
5.648500E-04 |
| Grade 2-vs-Grade 3 |
1.366030E-02 |
| Grade 2-vs-Grade 4 |
4.31619999963218E-07 |
| Grade 3-vs-Grade 4 |
1.678870E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.720600E-01 |
| Normal-vs-ccB subtype |
9.27550000140442E-08 |
| ccA subtype-vs-ccB subtype |
1.07230000001568E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.27709999999215E-05 |
| Normal-vs-N1 |
3.346200E-02 |
| N0-vs-N1 |
2.661000E-01 |
|
|
